TFX

Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types

Retrieved on: 
Tuesday, April 2, 2024
Urology, TFX, Development, Anatomy, ATC, Patient, Research and development, BPH, FDA, Physician, Medical imaging

The UroLift™ 2 System with Advanced Tissue Control (UroLift™ 2 ATC) has received FDA clearance, marking a significant advancement in BPH care.

Key Points: 
  • The UroLift™ 2 System with Advanced Tissue Control (UroLift™ 2 ATC) has received FDA clearance, marking a significant advancement in BPH care.
  • Bringing the enhanced tissue control capabilities onto the innovative and proven UroLift™ 2 platform allows me to deliver unparalleled precision to treat a broad spectrum of patients and anatomies.
  • It has transformed my approach to BPH care,” said Dr. Adam Craig Thomas of Parkview Physicians Group Urology in Fort Wayne, Indiana.
  • It ensures I’m always equipped to treat a broad range of patients with unique prostate types and anatomies.”
    To learn more about UroLift™ 2 ATC, visit UroLift.com .

Teleflex’s Climate Targets Validated by the Science Based Targets Initiative

Retrieved on: 
Thursday, March 28, 2024
TFX, Climate change, Science Based Targets initiative, Environment, GHG, Patient, Travel, Science, Climate, Corporate social responsibility, Ambition, Targets, Renewable energy

WAYNE, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced its near- and long-term climate change targets have been validated by the Science Based Targets initiative (SBTi).

Key Points: 
  • WAYNE, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced its near- and long-term climate change targets have been validated by the Science Based Targets initiative (SBTi).
  • The announcement comes ahead of the company’s release of its 2023 Global Impact Report, which will be published in May 2024.
  • Teleflex has responded to the SBTi’s urgent call for corporate climate action by committing to align with 1.5°C and net-zero through the Business Ambition for 1.5°C campaign.
  • Through the establishment and validation of the near-and long-term science-based emissions targets, Teleflex has committed to reaching net-zero greenhouse gas emissions (GHG) across its value chain by 2050.

Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)

Retrieved on: 
Thursday, March 14, 2024
Class Action Lawsuit, Professional Services, Legal, Teleflex, GPM, TFX, Helmsley Building, Suite

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors’ and officers’ possible violations of state laws.

Key Points: 
  • Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors’ and officers’ possible violations of state laws.
  • If you inquire by email please include your mailing address, telephone number, and the number of shares purchased and held.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20240314529066/en/

Lowey Dannenberg, P.C. Announces an Additional Settlement for Those Who Have Transacted in Euroyen-Based Derivatives Between January 1, 2006 through June 30, 2011

Retrieved on: 
Thursday, March 21, 2024
Barclays, J. P. Morgan, Agreement, Hearing, JPMorgan Chase, E pluribus unum, HSBC (United Kingdom), HSBC Bank, HSBC, American Bankers Association, Bank, TP ICAP, Chase Bank, Singapore Exchange, UBS AG, Sumitomo Mitsui Banking Corporation, Class, Lawyer, Interbank, Citibank, National Association, Person, Citigroup, Fairness, Tokyo Financial Exchange, Negotiation, GBD, Mitsubishi Group, District court, UBS, Defendant, Vexatious litigation, Knowledge, Settlement, Resona Holdings, TP, Norinchukin Bank, Shinkin Central Bank, TFX, Prior, Government, Société Générale, Plaintiff, Notice, CME, Conspiracy theory, Chicago Mercantile Exchange, ICAP, Court

The Settlement will provide an additional $35,000,000 to pay claims from persons who transacted in Euroyen-Based Derivatives from January 1, 2006 through June 30, 2011, inclusive.

Key Points: 
  • The Settlement will provide an additional $35,000,000 to pay claims from persons who transacted in Euroyen-Based Derivatives from January 1, 2006 through June 30, 2011, inclusive.
  • Before any money is paid, the Court will hold a Fairness Hearing to decide whether to approve the Settlement.
  • Contact your brokerage firm to see if you purchased, sold, held, traded, or otherwise had any interest in Euroyen-Based Derivatives.
  • These payments will also be deducted from the Settlement Fund before any distributions are made to the Settlement Class.

Teleflex Announces Quarterly Dividend

Retrieved on: 
Thursday, February 22, 2024
TFX, Teleflex

WAYNE, Pa., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.

Key Points: 
  • WAYNE, Pa., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.
  • The dividend is payable March 15, 2024, to shareholders of record at the close of business on March 1, 2024.
  • Additional information about Teleflex can be obtained from the company’s website at teleflex.com .

Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference

Retrieved on: 
Tuesday, February 20, 2024
TFX, Teleflex, Conference

WAYNE, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 5, 2024, at 1:40 p.m. (ET).

Key Points: 
  • WAYNE, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 5, 2024, at 1:40 p.m. (ET).
  • A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at teleflex.com .

Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information

Retrieved on: 
Thursday, February 8, 2024
TFX, Telephone, Teleflex, ID

WAYNE, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 22, 2024.

Key Points: 
  • WAYNE, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 22, 2024.
  • To participate in the conference call, please utilize this link to pre-register and receive the dial-in information.
  • An audio replay of the call will be available beginning at 11:00 am Eastern Time on February 22, 2024, either on the Teleflex website or by telephone.
  • The call can be accessed by dialing 1 800 770 2030 (U.S.) or 1 647 362 9199 (all other locations).The conference ID is 69028.

The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube™ Surgical Operating Tube

Retrieved on: 
Monday, January 29, 2024
ASG, TFX, Silo, Patent, United, Health, Antibiotics

CARLSBAD, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 11,832,853 entitled “Hybrid Radiolucent Surgical Operating Tube”.

Key Points: 
  • CARLSBAD, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 11,832,853 entitled “Hybrid Radiolucent Surgical Operating Tube”.
  • Aurora Spine’s Ghost Tube™ was designed to provide superior anchoring with a translucent thermoplastic body and non-slipping titanium anchors to assure that minimally invasive surgical access will stay stationary to support surgical preparation tools without blocking x-ray visualization during surgery.
  • "Aurora Spine has created several disruptive technologies in the past 12 years”, said Trent Northcutt, President & CEO of Aurora Spine. "
  • Aurora will continue being disruptive and innovative by looking at ways to efficiently deliver our products and create and improve new treatment options to improve patient care and overall patient outcomes.”

AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETING

Retrieved on: 
Thursday, January 18, 2024
ASG, Patient, Silo, Synovial joint, TFX, Journal, Sacroiliac joint, Physician

CARLSBAD, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the North American Neuromodulation Society (“NANS”) Annual Meeting from January 18-21 in Las Vegas, Nevada.

Key Points: 
  • CARLSBAD, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the North American Neuromodulation Society (“NANS”) Annual Meeting from January 18-21 in Las Vegas, Nevada.
  • The NANS Annual Meeting is a prominent medical conference that brings together healthcare professionals, researchers, and experts in the field of neuromodulation.
  • Aurora will be showcasing two Sacroiliac Joint (SI Joint) fusion products.
  • Silo TFX and Silo offer physicians options to stabilize the SI Joint, helping patients with access to treatment for their SI joint dysfunction.

CES 2024: The Global Platform Defining Our Future

Retrieved on: 
Saturday, January 13, 2024
Digital health, Nu Skin Enterprises, IPS, Artificial intelligence, Advertising, C space, Walmart, Mobility, Elevance Health, Human, D-NV, Assistant, Privacy, Consumer Technology Association, Policy, Health equity, UN, TFX, Recycling, Centennial, Transport, EssilorLuxottica, Investment, Marketing, Force, HD Hyundai, CTA, Generation Z, FCC, Tech, Innovation, AI, Therapy, CES, Content, Telehealth, Intel, FTC, ARIA, ALL, Treasury, Partnership, Ecosystem, All, CPSC, FDA, CMOS, Patient safety, Research, News, Universal design, Medical device

LAS VEGAS, Jan. 13, 2024 /PRNewswire/ -- CES® 2024 closes today, after an exhilarating week that set the technology narrative for the year ahead. With 4300+ exhibitors, including a record 1400+ startups from around the globe in Eureka Park®, CES showcased the innovative trends shaping tomorrow and solving the world's most pressing challenges.

Key Points: 
  • Across the show and on CES conference stages, thousands of global brands announced new visions, products, investments and partnerships," said Kinsey Fabrizio, CTA Sr. VP, CES and membership.
  • Artificial Intelligence – AI led the global conversation at CES 2024.
  • This week at CES, Force for Good released a new report at the CES Research Summit on tech's influence on human securities.
  • Mobility – With 600+ mobility exhibitors, CES is one of the world's largest and fastest growing global auto, mobility and transportation events.